Future Directions for Laboratory Animal Law in the United States: Workshop
|
|
- Adrian McDowell
- 6 years ago
- Views:
Transcription
1 Future Directions for Laboratory Animal Law in the United States: Workshop Lawrence Schook, Ph.D. Gutgsell Professor University of Illinois at Urbana-Champaign
2 Presentation Outline Perspective: Personal path & Setting the Stage Changing Animal Research Landscape Myths and Facts Path Forward: Defining roles and responsibilities
3 Perspective: Personal path 1. Researcher using rodents, wild and farm animals 2. Medical, veterinary and agricultural faculties 3. Urban, rural and wild environments 4. Endpoint to variable phenotypic models (LD 50 to quantitative traits) 5. Private, foundational and governmental sources (NSF, DOD, USDA and NIH) 6. Single to multi-pi, multi-institutional grants 7. International research programs (Asia, South America, and Europe). 8. Student, investigator, department head, associate dean for research, vice president for research.
4 Setting the Stage AWA exempts animals used in agricultural research. Not a species issue but a research outcomes issue. Personal activities utilize the pig- must address its current exemption in food and fiber research. As a biomedical model as an initially healthy animals subjected to potentially or truly painful or distressful procedures. Focus on addressing costs (effort and financial) through efficiencies rather than standards.
5 NIH Model Organisms for NIH Biomedical Model Organisms Research for ISAG Amsterdam, 2008 Biomedical Research
6
7 NIH justifications for large animal genome sequencing The Long and Winding Road: From Genotype to Phenotype Improve health Inform biology Inform sequences (comparative) Expand knowledge of biological processes Provide surrogate experimental systems Facilitate positional cloning Expand understand of evolutionary processes
8 Creating and Effectively Evaluating Clinically Relevant Animal Models Exp. Biol. Med. 229: , Current Enabling Technologies Available Genome sequence information Conditional transgenesis Recombineering Comparative/Functional genomics Multiple allelic substitutions Proteomics/metabolomics Bioinformatics/predictive profiling
9 The TJ Tabasco Genome Story Google Other Species images and Research Purposes
10 The TJ Tabasco Genome Story: A Porcine Blueprint for Agriculture, Life and Biomedical Sciences AGRICULTURAL SCIENCES: Genotypes and Phenotypes
11 The TJ Tabasco Genome Story: A Porcine Blueprint for Agriculture, Life and Biomedical Sciences BIOMEDICAL SCIENCES: Designing Cancer Models
12 The TJ Tabasco Genome Story: A Porcine Blueprint for Agriculture, Life and Biomedical Sciences LIFE SCIENCES: Mechanisms of Mammalian, Evolution and Diversity
13 The TJ Tabasco Genome Story: A Porcine Blueprint for Agriculture, Life and Biomedical Sciences DNA-based Models
14 Multi-PI, Multi-Institutional, Multi-National
15
16 Co-Clinical Trials: Oncopig Cancer Model Tumor Number of nodules Location Size Patient Co-morbidity (cirrhosis, NASH, obesity) Performance status (ECOG) Gender/age
17 Roles and Responsibilities Pathway of regulations The Who? Form follows function- defining roles and responsibilities Oversight- funders require specific statements, tremendous professional oversight; difference between making rules and enforcing Research Community
18 Demystifying Myths Researchers don t care about their animals Policing is necessary or people will never follow the rules Punishment is a strong motivator for ensuring quality welfare and care. Standards are critical to insuring
19 Building on Truths Animal facilities, housing and security have greatly advanced Quality of animals from breeding to health standards are unquestionable Monitoring of animals and their environments is exceptional People from IACUC to animal care to researchers provide the highest care for animals. Lead international vision discussion
20 Outcomes Reproducible robust results Progress Reducing costs through effectiveness Defining the what is broken Defining the who fixes and avoids
21
22 Defining the Right Path Forward Reducing patchwork of regulations Defining roles and responsibilities Funding agencies Compliance (FDA with GMO food animals) Host Institutions Researchers Defining outcomes
23 Streamlining: Authority and Risks Single office (reporting structure) All funding agencies request same Risk and complexity levels (like rdna BS levels) Standardized protocols for all to access (Wiki) Rules and Regulatory Process Efficiency to lower cost but reduce standards Like IRB, NCI has a IRB for all who receive funding to use
24 Animal Research Risk and Training Levels: Based on Pain, Complexity
25 Colleagues Extraordinaire Harris Lewin & Jon Beever Schook Laboratory Chuck Ray, Regina Schwind & Ron Gaba Greger Larsen & Martien Groenen
Recombinant DNA and Research with Animals
Recombinant DNA and Research with Animals Recombinant DNA and Research with Animals Jan V. Parker-Thornburg, Ph.D. Director, Transgenic Animal Core Facility MD Anderson Cancer Center Stephen H. Hughes,
More informationCITI Certificates
CITI Certificates 2017-2018 Adu.Research.Office@adu.edu Room CC340 Table of Contents Human Subjects Research... 1 Biomedical Research - Basic/Refresher - Basic Course:... 1 Required Courses:... 1 Human
More informationDigital Quality Summit. Charles Jaffe, MD, PhD CEO Health Level 7
Digital Quality Summit Charles Jaffe, MD, PhD CEO Health Level 7 Many Thanks to our Sponsors This is Jack s story This is Jack Honor student Football hero University-bound Jack complained to his Family
More informationRESEARCH INTEGRITY THE ABCS OF IACUC, IBC, IRB, AND MTAS AT UNF. Dawn P. O Connor Assistant Director for Research Integrity
RESEARCH INTEGRITY THE ABCS OF IACUC, IBC, IRB, AND MTAS AT UNF Dawn P. O Connor Assistant Director for Research Integrity RESEARCH INTEGRITY (RI)- ACTIVE ADHERENCE TO ETHICAL PRINCIPLES AND PROFESSIONAL
More informationTranslational Medicine From Discovery to Health
Translational Medicine From Discovery to Health Jamal A. Ibdah, MD, PhD Sr. Associate Dean & Director, MU Institute for Clinical and Translational Science Translational Medicine Translational Medicine
More informationThe Scripps Research Institute IBC. How a not for profit research
The Scripps Research Institute IBC How a not for profit research institute runs its IBC TSRI La Jolla Campus Who are we? TSRI History Scripps Metabolic Clinic was founded in 1924 by Ellen Browning Scripps
More informationWorking with Animals. Walter Jeske, PhD Professor, Thoracic & CV Surgery, Pathology, Physiology Vice-chair, IACUC 02/27/14
Working with Animals Walter Jeske, PhD Professor, Thoracic & CV Surgery, Pathology, Physiology Vice-chair, IACUC 02/27/14 Animal research is as carefully regulated as human research but for different
More informationSynthetic Biology. Todd Kuiken, Ph.D
Synthetic Biology Todd Kuiken, Ph.D. todd.kuiken@wilsoncenter.org 202-691-4398 Outline Synbio Landscape in Funding and Applications New actors in the space Forgotten Biosecurity Issues: Ecology Gene Drives
More informationStrasser, Jane (strassje)
Strasser, Jane (strassje) From: Strasser, Jane (strassje) Sent: Tuesday, April 12, 2011 11:35 AM To: UC-COMP-MATTERS@LISTSERV.UC.EDU Subject: [UC-COMP-MATTERS] Compliance Matters--April
More informationREGISTRATION DOCUMENT FOR RECOMBINANT DNA RESEARCH
EHRS Date Received: Reg. Doc. No.: REGISTRATION DOCUMENT FOR RECOMBINANT DNA RESEARCH Principal Investigator: Penn ID#: Position Title: School: Department: Mailing Address: Mail Code: Telephone: FAX: E-mail:
More informationUniversity Council on Animal Care
Policy: Animal Use Protocols Category: Administration Subject: The generation, review and approval of Animal Use Protocols Approving Authority: University Council on Animal Care Responsible Office: Animal
More informationIBC protocol Risk Assessment and Determination of NIH Guidelines
IBC protocol Risk Assessment and Determination of NIH Guidelines The following are points to consider when reviewing all protocols for risk, recommended containment conditions, and determine applicable
More informationSafe Operating Procedure
Safe Operating Procedure RECOMBINANT OR SYNTHETIC NUCLEIC ACIDS IBC AND OTHER REVIEW REQUIREMENTS (For assistance, please contact EHS at (402) 472-4925, or visit our web site at http://ehs.unl.edu/) (Revised
More informationANIMAL USE PROPOSAL BREEDING COLONY
INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE Graduate Science Research Center, Suite 102 803/777-8106 Fax 803/777-2849 ANIMAL USE PROPOSAL BREEDING COLONY IACUC Approval Number Date Approved For Office
More information18.0 INSTITUTIONAL BIOSAFETY COMMITTEE
18.0 INSTITUTIONAL BIOSAFETY COMMITTEE 18.1 INTRODUCTION... 1 18.2 BIOLOGICAL SAFETY COMMITTEE SCOPE AND MISSION STATEMENT... 1 18.3 DEFINITION OF A BIOLOGICAL AGENT... 2 18.4 REVIEW CLASSIFICATION...
More informationA Roadmap to Biomanufacturing
MASSACHUSETTS INSTITUTE OF TECHNOLOGY A Roadmap to Biomanufacturing INTRODUCTION Join us in Principles of Biomanufacturing: Using Biotechnology to Manufacture Medicines and earn 3 CEUs and a MIT Professional
More informationClinical Research at MSU
Financial Administration Development Program: Clinical Research at MSU Kristen Burt, Office of Regulatory Affairs (ORA) Sharon Schooley, Clinical & Translational Sciences Institute (CTSI) February 24,
More informationNew breeding technologies in plant sciences
New breeding technologies in plant sciences GPC-SEB workshop, 7-8 July 2017, Gothenburg, Sweden Historical Evolution of Biosafety Legislation and Key Definitions. Piet van der Meer 1986 2000: responsible
More informationNIH Guidelines for rdna Research: Tutorial for Completing Penn s rdna Registration Document
NIH Guidelines for rdna Research: Tutorial for Completing Penn s rdna Registration Document Revision March 3, 2011 Penn s rdna Registration Document Dual Use Research Definition: Research that yields information
More informationRare Diseases: Challenges and Opportunities NIH Perspective
Rare Diseases: Challenges and Opportunities NIH Perspective Stephen C. Groft, Pharm.D. Office of Rare Diseases Research (ORDR) National Center for Advancing Translational Science (NCATS) National Institutes
More informationOffice for Human Subject Protection. University of Rochester
POLICY 1. Purpose Outline the responsibilities and regulatory requirements when conducting human subject research that involves the use of drugs, agents, biological products, or nutritional products (e.g.,
More informationNew York University Institutional Biosafety Policy Updated 08/03/2015
New York University Institutional Biosafety Policy Updated 08/03/2015 New York University and its School of Medicine and College of Dentistry are committed to ensuring that the performance of basic and
More informationBiosafety and the NIH Guidelines
Biosafety and the NIH Guidelines This section will explore: Why the NIH Guidelines are important The definition of recombinant or synthetic nucleic acid research Content of the NIH Guidelines Section III
More informationIntroduction to Quantitative Imaging as a Biomarker in Clinical Trials
Quantitative Medical Imaging for Clinical Research and Practice Educational Session ACRIN 2009 Introduction to Quantitative Imaging as a Biomarker in Clinical Trials Katarzyna J. Macura, MD, PhD Johns
More informationTOPICS TOPICS. Navigating NIH 2016 Policy Changes for Grant Applications and Availability of Proposal Resources
Navigating NIH 2016 Policy Changes for Grant Applications and Availability of Proposal Resources John Ivy, Ph.D. Sr. Research Development Officer johnivy@tamu.edu Christina Papke, Ph.D. Research Development
More informationVertebrate Animal Use Protocol for Research or Testing
AUP #: ORC USE ONLY Vertebrate Animal Use Protocol for Research or Testing Date Received: Instructions and Researcher Certifications (Failure to follow may result in a delay in processing) Complete this
More informationINVESTIGATIONAL DEVICE EXEMPTIONS AND EARLY FEASIBILITY STUDIES TO SUPPORT DEVICE INNOVATION
INVESTIGATIONAL DEVICE EXEMPTIONS AND EARLY FEASIBILITY STUDIES TO SUPPORT DEVICE INNOVATION Maureen L. Dreher, PhD Policy Analyst, Clinical Trials Program Office of Device Evaluation/ CDRH www.fda.gov
More informationComments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants
Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 The American Society of Human Genetics 9650 Rockville Pike Bethesda, MD 20814 24 December
More informationTOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS
TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER
More informationSupply of IND Agents to Multi-center trials by Skilled Academic Sites
Supply of IND Agents to Multi-center trials by Skilled Academic Sites Paula M. Jacobs, Ph.D. Associate Director, Division of Cancer Treatment and Diagnosis, NCI Cancer Imaging Program June 2016 SNMMI San
More informationNIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules Department of Environment, Health and Safety 10/2017 This is the print version of the Recombinant or Synthetic Nucleic
More informationYale University. Open Data Access Project
Open Data Access Project A Model for Dissemination and Independent Analysis of Clinical Trial Program Data Funded by a contract with Medtronic, Inc. Rationale A substantial number of clinical trials are
More informationThe Research Services Organization (RSO) of the Academic Health Center
Annual Report 2005 The Research Services Organization (RSO) of the Academic Health Center A Summary of the Eighth Year of Operations Submitted by: Mark S. Paller, M.D., M.S. Director, Research Services
More informationevaluate risk / benefit implications ascertain applicability of existing legislation
1 Scope & purpose Regulatory implications of NBTs evaluate risk / benefit implications ascertain applicability of existing legislation assess robustness of current regulatory framework and risk analysis
More informationClinical Trials and the Code of Federal Regulations. Darlene Kitterman, MBA Director, Investigator Support & Integration Services September 24, 2014
Clinical Trials and the Code of Federal Regulations Darlene Kitterman, MBA Director, Investigator Support & Integration Services September 24, 2014 The Development of Regulations 1906: Food and Drugs Act
More information2010 HSC Biology Marking Guidelines
00 HSC Biology Marking Guidelines Section I, Part A Question Answer C D C C 5 B 6 B 7 A 8 D 9 C 0 D B A B D 5 D 6 B 7 C 8 D 9 D 0 C 00 HSC Biology Marking Guidelines Section I, Part B Question Correctly
More informationSECTION I CITIZENSHIP: CITIZENSHIP: SECTION II
APPLICATION FOR INSTITUTIONAL BIOSAFETY COMMITTEE REVIEW AND APPROVAL South Dakota School of Mines and Technology (Protocol Submission Form) This form must be submitted for ALL research or teaching activities
More informationBasics of Ethical Reasoning. ME 760 Biomedical Product Development
Basics of Ethical Reasoning ME 760 Biomedical Product Development Ethical Dilemma: Example 1 A research engineer in Large Corp X, a medical device company, was asked by the product development group to
More informationUVA Biorepository & Tissue Research Facility (BTRF) Coded-Specimens Guidance
Last Modified 09/15/2015 UVA Biorepository & Tissue Research Facility (BTRF) Coded-Specimens Guidance Setting up a new coded-specimens protocol with the IRB is very easy and will allow you to receive coded
More informationBIOTECHNOLOGY. Unit 8
BIOTECHNOLOGY Unit 8 PART 1 BASIC/FUNDAMENTAL SCIENCE VS. APPLIED SCIENCE! Basic/Fundamental Science the development and establishment of information to aid our understanding of the world.! Applied Science
More informationRegistration for the Use of Biological Materials
Form 01: Please return to: Registration for the Use of Biological Materials Environmental Health and Safety (EHS) 135 College St., Suite 100 Tel. 737-2121 Fax 785-7588 OEHS Use Only BSL: BBP State Select
More informationInstitutional Biosafety Committee (IBC) Handbook
Institutional Biosafety Committee (IBC) Handbook Table of Contents Purpose 2 Responsibilities 2 Membership. 4 Quorum 5 Meetings.. 5 Subcommittees 5 Protocol Review. 5 Criteria for Reviewing Protocols.
More informationCreating porcine biomedical models through recombineering
Comparative and Functional Genomics Comp Funct Genom 2004; 5: 262 267. Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/cfg.404 Conference Review Creating porcine biomedical
More informationIN THE UNITED STATES PATENT AND TRADEMARK OFFICE
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE In the matter of: Reexamination Control. No. 95/000,154 Art Unit: 3991 U.S. Patent No. 7,029,913 Issued: April 18, 2006 Examiner: Gary L. Kunz Inventor:
More informationMAS refers to the use of DNA markers that are tightly-linked to target loci as a substitute for or to assist phenotypic screening.
Marker assisted selection in rice Introduction The development of DNA (or molecular) markers has irreversibly changed the disciplines of plant genetics and plant breeding. While there are several applications
More informationLANDMARK AREA OF EXCELLENCE: BIOMEDICAL GENOMICS
Introduction LANDMARK AREA OF EXCELLENCE: BIOMEDICAL GENOMICS Genomics is a key and rapidly expanding research discipline that is adding new dimensions to the changing structure of modern biomedicine.
More informationBIOSAFETY REGISTRATION FORM
BRF 5/2015 Page 1 of 5 COMMITTEE USE ONLY 1. PERSONNEL TEMPLE UNIVERSITY Office of the Vice Provost for Research Division of Research Compliance Institutional Biosafety Committee Tel: (215) 707-9741, Fax:
More informationFOR OFFICE USE ONLY. IACUC PROTOCOL NUMBER: IACUC Approval has been granted for the project described in this document
ADMINISTRATIVE COVER SHEET FOR AN APPLICATION TO USE LIVE VERTEBRATE ANIMALS IN FIELD RESEARCH Arkansas Tech University Institutional Animal Care and Use Committee (IACUC) FOR OFFICE USE ONLY IACUC PROTOCOL
More information8/2/2017. Key attributes of scientific excellence: rigor, innovation, and relevance. Medical Physics 3.0. Key Attributes of Scientific Excellence
Medical Physics 3.0 in Design Key attributes of scientific excellence: rigor, innovation, and relevance Maryellen Giger, Ph.D. A. N. Pritzker Professor of Radiology / Medical Physics The University of
More informationBuilding a Biosafety Program from Scratch
Building a Biosafety Program from Scratch Ray Scheetz MS, RBP Institutional Biosafety Officer Compliance Specialist Office of Research Quality Assurance Penn State University College of Medicine rscheetz@pennstatehealth.psu.edu
More informationAn introduction to Danish animal welfare legislation and current animal welfare issues
An introduction to Danish animal welfare legislation and current animal welfare issues MoCaS, University of Copenhagen 6 September 2016 Per Henriksen, Chief Veterinary Officer Overview of the presentation
More informationWhat is Biotechnology? Micro 566 Microbial biotechnology Presented by Prof. Nagwa M. Aref
What is Biotechnology? Micro 566 Microbial biotechnology Presented by Prof. Nagwa M. Aref 1.1 Defining Biotechnology Biotechnology- the study and manipulation of living things or their component molecules,
More informationIACUC THE UNIVERSITY OF PITTSBURGH LEADER IN EDUCATION PIONEER IN RESEARCH PARTNER IN REGIONAL DEVELOPMENT
June 2011 IACUC Newsflash THE UNIVERSITY OF PITTSBURGH LEADER IN EDUCATION PIONEER IN RESEARCH PARTNER IN REGIONAL DEVELOPMENT In This Issue Library Center AAALAC Accredited Compliance Q & A Reminders,
More informationA Conversation about GMO Labeling Philip Miller PhD
A Conversation about GMO Labeling Philip Miller PhD Vice President of Global Regulatory and Government Affairs My journey through life Agriculture is at the center of global trends Population Growth 1960-2050
More informationExpanded Access and the Individual Patient IND
Expanded Access and the Individual Patient IND Research Wednesdays April 26, 2017 Erika Segear Johnson, PhD, RAC Associate Director of Regulatory Affairs Office of Regulatory Affairs and Quality Office
More informationStandard Statement and Purpose
Personnel Security Standard Responsible Office: Technology Services Initial Standard Approved: 10/23/2017 Current Revision Approved: 10/23/2017 Standard Statement and Purpose Security of information relies
More informationRochester Institute of Technology Institutional Biosafety Committee (IBC) Guidelines for Committee Authority, Structure and Responsibilities
1. Purpose The purpose of this document is to provide details of the responsibilities, scope of authority and structure of the. 2. Mission The mission of the Institutional Biosafety Committee is to: 2.1.
More informationInstitutional Biosafety Committee
Northern Illinois University Institutional Biosafety Committee Policy Office of Research Compliance, Integrity and Safety 2017 Northern Illinois University Institutional Biosafety Committee Purpose...
More informationHRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies
Genome Wide Association Studies HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date 1.0 Purpose This policy describes how investigators at the University of South Florida (USF) and USF Affiliates
More informationWebinar Tips Please mute your phone. Please do not put the call on hold. There will be time for questions after the presentation.
Webinar Tips Please mute your phone. Please do not put the call on hold. There will be time for questions after the presentation. Carolinas Collaborative Pilot RFA Webinar May 8, 2017 Partners Overview
More informationInstitutional Biosafety Committee. Policies and Procedures
Institutional Biosafety Committee Policies and Procedures September 2011 CONTENTS 1. INTRODUCTION 1.1 UNLV Institutional Biosafety Committee Roles and Responsibilities 1.2 The Foundation for IBC Review:
More informationGenomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC
Genomic Research: Issues to Consider IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC Outline Key genomic terms and concepts Issues in genomic research Consent models Types of findings Returning results
More informationTrends in Oversight of Human Research Protections?
Trends in Oversight of Human Research Protections? Greg Koski, PhD, MD Associate Professor, Harvard Medical School Senior Scientist, James Mongan Institute for Health Policy Former Director, Office for
More informationMAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE
MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE THE RESEARCH WE DO TODAY WILL DETERMINE THE TYPE OF MEDICAL AND SURGICAL PRACTICE WE CARRY ON AT THE CLINIC
More informationHuman Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987
Human Genomics, Precision Medicine, and Advancing Human Health Eric Green, M.D., Ph.D. Director, NHGRI The Human Genome Cells Nucleus Chromosome DNA Human Genome: 3 Billion Bases (letters) The Origin of
More informationGenomic Medicine in France
Genomic Medicine in France Catherine Nguyen, PhD Director ITMO GGB Genetic, Genomic & Bioinformatic Advancing Disease Modeling in Animal-Based research in Support of Precision Medecine: a Workshop ILAR
More informationThe Intersection of Genomics Research and the IDE Regulation
The Intersection of Genomics Research and the IDE Regulation Katherine Donigan, Ph.D. Personalized Medicine Staff FDA/CDRH/OIR October 19, 2017 1 In Vitro Diagnostic (IVD) Regulation Through the 1976 medical
More informationEthical Principles in Clinical Research. Disclaimer. Christine Grady Department of Bioethics NIH Clinical Center
Ethical Principles in Clinical Research Christine Grady Department of Bioethics NIH Clinical Center Disclaimer The views expressed are mine and do not necessarily represent the positions or policies of
More informationLearn More: Protecting Human Subjects Participating in Research and their Personal Privacy + NIH Clinical Trial & Common Rule Updates
RESEARCH ADMINISTRATION November 2017 Northeastern University Learn More: Protecting Human Subjects Participating in Research and their Personal Privacy + NIH Clinical Trial & Common Rule Updates Learning
More informationPerspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules
Perspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules Planning for Efficiencies of Data, Resources, and Timelines A PRECISION BRIEF Introduction
More informationMy Experiences as an FDA Statistician
My Experiences as an FDA Statistician Yeh-Fong Chen, Ph.D. FDA/CDER/OB/DB3 CBA 2016-2017 Workshop series-3 Dec. 18, 2016 Disclaimer This presentation reflects the views of the author and should not be
More informationJACKSON STATE UNIVERSITY INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC) APPLICATION FOR USE OF VERTEBRATE ANIMALS
JACKSON STATE UNIVERSITY INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC) APPLICATION FOR USE OF VERTEBRATE ANIMALS IACUC USE ONLY: Protocol No: Approval Date: Department: Expiration Date: 1 Protocol
More informationCOMMITTEE USE ONLY IBC REGISTRATION
BRF September 2016 Page 1 of 6 COMMITTEE USE ONLY IBC REGISTRATION # ASSOCIATED ACUP/IRB# Research Integrity and Compliance Institutional Biosafety Committee APPROVAL BIOSAFETY REGISTRATION FORM Tel: (215)
More informationPDUFA VI Public Meeting Remarks of Cynthia A. Bens Alliance for Aging Research. August 15, 2016
1 PDUFA VI Public Meeting Remarks of Cynthia A. Bens Alliance for Aging Research August 15, 2016 Panel 1: Pre-Market Review and Post-Market Safety Good morning everyone and thanks to the FDA for inviting
More informationNORTHEASTERN UNIVERSITY INSTITUTIONAL BIOSAFETY COMMITTEE CHARTER
NORTHEASTERN UNIVERSITY INSTITUTIONAL BIOSAFETY COMMITTEE CHARTER Date Approved: 7/11/17 Last Revision Date: 7/11/17 Introduction I. Purpose Northeastern University s (NU) Institutional Biosafety Committee
More informationCritical Path to TB Drug Regimens (CPTR)
Critical Path to TB Drug Regimens (CPTR) Why do we need a CPTR initiative? We finally have a pipeline of TB drug candidates Today, we test drugs same way we did 20 years ago Need better tests for drug
More informationPurdue Animal Care and Use Committee (PACUC) APPLICATION TO USE VERTEBRATE ANIMALS IN RESEARCH, TEACHING, OR TESTING
Principal Investigator/Project Director: Protocol Title: Coeus Protocol Number: Purdue Animal Care and Use Committee (PACUC) APPLICATION TO USE VERTEBRATE ANIMALS IN RESEARCH, TEACHING, OR TESTING IACUC
More informationSummary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015
Pediatric-Specific Provisions Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Requires the NIH to complete a strategic plan, and in the
More informationTutorial for Completing Penn s r s DNA Registration Document
NIH GUIDELINES FOR RESEARCH INVOLVING RECOMBINANT OR SYNTHETIC NUCLEIC ACID MOLECULES NIH GUIDELINES Tutorial for Completing Penn s r s DNA Registration Document Revision March 7, 2013 Penn s r s DNA Registration
More informationLivestock Genomics: The Odyssey
Livestock Genomics: The Odyssey Jim Womack, Texas A&M University NRSP-8 Animal Genome Workshop Plant and Animal Genome XX, Jan 15, 2012 Thanks, Geoff and Workshop Committee BRD? Rift Valley Fever? HISTORY!!!
More informationLunch-N-Learn. National C-FAR Hill Seminar Series. National Coalition for Food and Agricultural Research (National C-FAR)
Lunch-N-Learn National C-FAR Hill Seminar Series National Coalition for Food and Agricultural Research (National C-FAR) FARM ANIMALS: A NEGLECTED RESEARCH RESOURCE FOR ADVANCING HUMAN HEALTH AND ANIMAL
More informationActivities of the Korean Association of the Institutions Review Boards (KAIRB) in the year of Korea
Activities of the Korean Association of the Institutions Review Boards (KAIRB) in the year of 2002-2003 Korea October 18, 2003 Ock-Joo Kim, M.D., Ph.D. General Secretary of KAIRB (Seoul, Korea) I. Foundation
More informationBasic Training Module for Research Personnel
Basic Training Module for Research Personnel Welcome to the IU Bloomington (IUB) Training Program in Laboratory Animal Care and Use. This Basic Module for Research Personnel is required for all faculty,
More informationAdvertising and Marketing Genetic Tests New Pathways or Old Roads?
Advertising and Marketing Genetic Tests New Pathways or Old Roads? Kathleen M. Sanzo, Morgan Lewis FDLI Advertising & Promotion Conference Wednesday, September 28, 2016 Context for Use of Genetic Tests
More informationCTTI Overview One Decade of Impact. One Vision Ahead.
Feb. 6, 2018 CTTI Overview One Decade of Impact. One Vision Ahead. Pamela Tenaerts, MD, MBA Executive Director #CelebrateCTTI Discover how CTTI has influenced the clinical trials enterprise during the
More informationOBJECTIVES-ACTIVITIES 2-4
OBJECTIVES-ACTIVITIES 2-4 Germplasm Phenotyping Genomics PBA BIMS MAB Pipeline Implementation GOALS, ACTIVITIES, & DELIVERABLES Cameron Peace, project co-director & MAB Pipeline Team leader Outline of
More informationHuman Subjects Protection: Training for Research Teams
Human Subjects Protection: Training for Research Teams Walter L. Calmbach MD MPH South Texas Ambulatory Research Network (STARNet) Dept. of Family & Community Medicine Univ. of Texas Health Science Center
More informationApplications of Big Data in Evidence-Based Medicine
Applications of Big Data in Evidence-Based Medicine Carolyn Compton, MD, PhD Professor Life Sciences, Arizona State University Professor Laboratory Medicine and Pathology, Mayo Clinic Adjunct Professor
More informationRegistration Document For Biohazards
Protocol #: Registration Document For Biohazards All applicants are required to complete the following sections: Principal Investigator Information Location of Study Section A: General Administrative Information
More informationOutline of Discussion
This final rule is intended to better protect human subjects involved in research, while facilitating valuable research and reducing burden, delay, and ambiguity for investigators. These revisions are
More informationNEW MEXICO HIGHLANDS UNIVERSITY ANIMAL STUDY PROPOSAL
NEW MEXICO HIGHLANDS UNIVERSITY ANIMAL STUDY PROPOSAL Proposal #: Leave Blank PLEASE TYPE A. ADMINISTRATIVE DATA Approval Date: Expiration Date: Department: Principal Investigator: Mailing Address: Telephone:
More informationINVESTIGATIONAL DEVICE EXEMPTION APPLICATION. IDE Title (if title being used)
INVESTIGATIONAL DEVICE EXEMPTION APPLICATION IDE Title (if title being used) Name of Sponsor Investigator, MD X Professor, Department Icahn School of Medicine at Mount Sinai Date of Submission Form version
More informationInstructions for Biosafety Application Research and Sponsored Programs 201J University Hall Wright State University Dayton, OH (937)
Instructions for Biosafety Application Research and Sponsored Programs 201J University Hall Wright State University Dayton, OH 45435 (937) 775-2425 Please use the attached application for requesting a
More informationNEW AUP FORM AND INSTRUCTIONS.
Animal Care Matters An IACUC and ARF e-newsletter From the IACUC Administrator Stephanie Cook Fall 2008 As mentioned in last quarter s newsletter, many of the IACUC s forms, policies, and procedures are
More informationClinical Trials: Registration, Results Reporting, and Data Sharing
Clinical Trials: Registration, Results Reporting, and Data Sharing Jerry Sheehan Assistant Director for Policy Development National Library of Medicine National Institutes of Health OECD Expert Workshop
More informationWhat is the Future of NIH funded Clinical Research in IBD?
IBD Clinical Trials Workshop What is the Future of NIH funded Clinical Research in IBD? Stephen P. James, M.D. January 13-14, 2017 Future? FY 2015 NIH Awards for IBD related research 338 Awards $128 Million
More informationInstitutional Biosafety Committee
Biosafety Program Institutional Biosafety Committee IBC JOHN A. BURNS SCHOOL OF MEDICINE & UH CANCER CENTER RESEARCH COMPLIANCE WEEK OCTOBER 20, 2016 H U B E R T O L I P A R E S A N I M A L W E L F A R
More informationWESTERN CONNECTICUT STATE UNIVERSITY Institutional Animal Care and Use Committee (IACUC) PROTOCOL FOR RESEARCH WITH VERTEBRATE ANIMALS
IACUC-1 Form (Rev. 12/17/15) OFFICE USE ONLY IACUC LOG # Approval Date Expiration Date WESTERN CONNECTICUT STATE UNIVERSITY Institutional Animal Care and Use Committee (IACUC) PROTOCOL FOR RESEARCH WITH
More informationThe Science of Small Clinical Trials
The Science of Small Clinical Trials Introduction to Small Clinical Trials an Industry Perspective Simon Day, PhD Confucius (allegedly) When it is obvious that the goals cannot be reached, don t adjust
More informationCritical Path Initiative: An Update
Critical Path Initiative: An Update Raymond Woosley, MD, PhD President and CEO, Critical Path Institute Presented at: FIRST ANNUAL PATIENT-REPORTED OUTCOMES (PRO) CONSORTIUM WORKSHOP March 23, 2010 Bethesda,
More information